Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.
Barbare JC, Bouché O, Bonnetain F, Dahan L, Lombard-Bohas C, Faroux R, Raoul JL, Cattan S, Lemoine A, Blanc JF, Bronowicki JP, Zarski JP, Cazorla S, Gargot D, Thevenot T, Diaz E, Bastie A, Aparicio T, Bedenne L.
Barbare JC, et al. Among authors: bonnetain f.
Eur J Cancer. 2009 Jul;45(10):1788-97. doi: 10.1016/j.ejca.2009.02.018. Epub 2009 Mar 19.
Eur J Cancer. 2009.
PMID: 19303768
Clinical Trial.